Monday 19 October 2026
Export VJET’s income statement to Excel — free account
Flyte Aviation, Inc.
VJET Healthcare Medical Devices
Flyte Aviation, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $819,000.00, up 95.0% from fiscal 2024. In the quarter to June 2026, revenue grew 380.7%, EPS grew 87.3%, free cash flow fell 26.7% and total debt rose 160.0%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.
0.84
0.14
−14.29%
Follow VJET
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 3 | 2 | 1 | 3 | 4 | 2 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 14,265,259.50 | 7.65 | (2.30) | (9.75) | (16.90) | (19.48) | (15.46) | (30.65) |
P/S ratio |
0.00 | 0.00 | 27,852,635.05 | 37.28 | 545.06 | 4,510.43 | 3,407.40 | 49.69 | 34.97 | 24.15 |
Altman Z″-Score (non-manufacturers) |
(13.29) | (15.20) | 9.68 | (9.94) | (16.35) | (31.37) | (45.59) | (43.63) | (36.02) | (73.28) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (6.98) | (2.25) | — | — | — | — | — | (4.34) | (4.90) |
P/Operating CF |
(108,830,132.73) | (108,830,132.73) | (20,749,367.48) | (28.04) | (15.00) | (18.16) | (21.40) | (11.63) | (5.13) | (13.08) |
P/B ratio |
0.00 | 0.00 | 2,612,606.81 | 8.10 | 6.68 | 7.59 | 6.99 | 1.04 | 1.25 | 2.97 |
Price to Tangible BV |
0.00 | 0.00 | 2,612,606.81 | 8.10 | 6.68 | 7.59 | 6.99 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 27,852,624.91 | 33.11 | 459.88 | 3,953.96 | 2,678.56 | 42.43 | 32.48 | 28.12 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(33,542,301.33) | (33,542,301.33) | (9,416,137.56) | (7.19) | (4.21) | (3.29) | (2.26) | (0.91) | (1.47) | (2.78) |
EV/FCF |
(31,363,839.83) | (31,363,839.83) | (9,129,066.21) | (7.13) | (4.20) | (3.33) | (2.26) | (0.91) | (1.46) | (2.77) |
Quick Ratio |
1.59 | 3.32 | 11.03 | 4.60 | 3.08 | 2.80 | 2.09 | 1.50 | 1.32 | 0.06 |
Current Ratio |
1.96 | 3.81 | 11.64 | 5.28 | 3.56 | 3.17 | 2.22 | 1.68 | 1.48 | 0.10 |
Net Debt/EBITDA |
0.93 | 0.47 | 2.08 | 0.54 | 0.67 | 0.47 | 0.60 | 0.05 | 0.14 | (0.16) |
Debt/Assets |
1.83% | 0.56% | 1.15% | 1.27% | 5.51% | 9.41% | 0.00% | 0.00% | 5.62% | 19.41% |
Debt/Equity |
(0.28) | (0.01) | 0.01 | 0.02 | 0.09 | 0.14 | 0.00 | 0.00 | 0.13 | 0.46 |
Asset Turnover |
0.70 | 0.69 | 0.15 | 0.12 | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 | 0.04 |
Operating CF/Net income |
0.45 | 0.31 | 0.60 | 0.58 | 0.79 | 1.10 | 0.84 | 0.29 | 0.43 | 0.48 |
Capex/Depreciation |
0.00 | (2.51) | (0.93) | (0.15) | (0.03) | 0.21 | 0.05 | (0.04) | (0.03) | (0.01) |
Interest Coverage |
(2,798.67) | (4,440.00) | (2,225.71) | (230.92) | (274.43) | — | — | — | (123.55) | (75.24) |
| 105.12% | 444.40% | (104.36%) | (114.08%) | (132.77%) | (144.00%) | (234.29%) | (468.74%) | (132.33%) | (186.69%) | |
| (49.11%) | (207.64%) | (72.29%) | (96.44%) | (93.00%) | (92.03%) | (141.84%) | (300.06%) | (74.53%) | (78.77%) | |
ROIC |
0.00% | 0.00% | (601.08%) | (1,152.39%) | 0.00% | (3,003.49%) | 0.00% | (276.97%) | (67.28%) | (137.06%) |
Return on Tangible Assets |
(135.37%) | (207.34%) | (45.31%) | (166.37%) | (161.02%) | (185.59%) | (290.12%) | (4,057.53%) | (1,890.81%) | 497.63% |
Average Days of Receivables |
24.00 | 32.15 | 77.00 | 39.85 | 33.82 | 348.41 | 0.00 | 113.13 | 60.83 | 69.08 |
Research and Development Expense of Revenue |
28.70% | 76.97% | 44.37% | 62.93% | 3,457.53% | 55,695.45% | 45,657.14% | 107.47% | 64.76% | 105.25% |
Selling, General and Administrative Expense of Revenue |
89.04% | 254.63% | 486.42% | 716.06% | 9,472.20% | 70,340.91% | 116,071.43% | 3,873.76% | 2,702.14% | 1,474.36% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.86 | 0.87 | 0.96 |
Share Based Compensation of Revenue |
0.00% | 216.46% | 235.38% | 327.03% | 1,576.06% | 10,168.18% | 3,192.86% | 275.34% | 12.86% | 41.27% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.09 | 0.11 | 0.09 | 0.14 | (0.24) | (0.87) | (0.45) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(8.66%) | (8.66%) | 0.00% | (6.38%) | (42.57%) | (36.30%) | (40.76%) | (321.09%) | (113.31%) | (101.90%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | (12.46%) | (20.10%) | (26.31%) | (34.76%) | (94.22%) | (63.57%) | (42.04%) |
Revenue per Share |
11.77 | 0.78 | 0.68 | 71,990.00 | 1,295.00 | 44.00 | 2.59 | 15.29 | 2.44 | 0.76 |
Operating CF per Share |
(3.72) | (0.73) | (2.01) | (331,730.00) | (141,520.00) | (55,250.00) | (4,179.26) | (713.46) | (53.96) | (7.68) |
Capex per Share |
0.00 | (0.07) | (0.06) | (2,680.00) | (335.00) | 658.00 | 3.89 | (2.63) | (0.39) | (0.02) |
Free Cash Flow per Share |
(3.72) | (0.80) | (2.07) | (334,410.00) | (141,855.00) | (54,592.00) | (4,175.37) | (716.09) | (54.35) | (7.69) |
Cash per Share |
7.72 | 1.09 | 6.97 | 305,770.00 | 119,530.00 | 30,090.00 | 2,936.85 | 123.36 | 16.72 | 0.08 |
Shareholders Equity per Share |
(0.75) | (1.01) | 7.23 | 331,500.00 | 105,735.00 | 27,346.00 | 1,714.81 | 733.32 | 68.43 | 6.15 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.75) | (1.01) | 7.23 | 331,500.00 | 105,735.00 | 27,346.00 | 1,714.81 | 733.32 | 68.43 | 6.15 |
Free Cash Flow |
(1.89) | (6.07) | (19.09) | (33.44) | (28.37) | (27.30) | (22.55) | (20.69) | (9.34) | (8.31) |
Working Capital |
2.60 | 7.41 | 63.28 | 29.19 | 19.86 | 11.70 | 9.26 | 1.69 | 1.06 | (3.52) |
Capital Expenditures |
(0.21) | (0.55) | (0.58) | (0.27) | (0.07) | 0.33 | 0.02 | (0.08) | (0.07) | (0.02) |
Net Current Asset Value |
(0.91) | (8.84) | 61.90 | 25.07 | 15.33 | 9.72 | 9.26 | (5.38) | (12.72) | (8.82) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.09 | 0.09 | 0.04 | 0.26 | (14.95) | (1.50) | 0.17 | 0.16 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.19 | 0.13 | 0.35 | 0.94 | 0.87 | 0.00 | 29.64 | 23.18 | 33.05 |
Cash ROIC |
(51.70%) | (886.13%) | (14.48%) | (52.02%) | (60.50%) | (88.91%) | (89.76%) | (83.59%) | (57.67%) | (84.68%) |
Accounts Receivable Turnover |
13.13 | 12.90 | 6.81 | 6.84 | 0.64 | 0.98 | 0.00 | 5.59 | 4.06 | 7.28 |
Accounts Payable Turnover |
6.98 | 9.27 | 5.42 | 6.66 | 2.17 | 2.14 | 0.30 | 0.11 | 0.12 | 0.07 |
Inventory Turnover |
3.04 | 4.03 | 2.55 | 3.63 | 1.19 | 1.67 | 0.00 | 0.06 | 1.09 | 1.06 |
Average Days of Payables |
55.02 | 37.33 | 97.63 | 63.18 | 79.15 | 231.17 | 208.57 | 5,645.33 | 1,998.81 | 8,644.13 |
Days of Inventory on Hand |
101.20 | 104.81 | 181.98 | 114.53 | 147.38 | 230.70 | 0.00 | 535.33 | 286.79 | 498.25 |
Average Receivables |
0.46 | 0.46 | 0.92 | 1.05 | 0.41 | 0.02 | — | 0.08 | 0.10 | 0.11 |
Average Payables |
0.45 | 0.45 | 0.78 | 1.33 | 1.00 | 0.73 | 0.54 | 0.28 | 0.35 | 0.86 |
Average Inventory |
1.03 | 1.03 | 1.65 | 2.44 | 1.83 | 0.93 | — | 0.52 | 0.04 | 0.06 |
Average Assets |
8.56 | 8.56 | 42.65 | 59.06 | 38.76 | 27.24 | 18.94 | 23.79 | 29.25 | 21.82 |
Average Common Equity |
(4.00) | (4.00) | 29.55 | 49.93 | 27.15 | 17.41 | 11.47 | 15.23 | 16.48 | 9.20 |
Columns are period end dates